Bioinformatics Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

Revenue, 2025

USD 18.69 Bn

Forecast Year, 2035

USD 56.55 Bn

CAGR, 2026 - 2035

11.71%

Report Coverage

Global

What is the Bioinformatics Market Size?

The global bioinformatics market size accounted for USD 18.69 billion in 2025 and is expected to exceed USD 56.55 billion by 2035, growing at a CAGR of 11.71% from 2026 to 2035. The growing investment in biology and information technology industries is directly having a positive impact on the growth of bioinformatics market.

Bioinformatics Market Key Takeaways

• North America dominated the global bioinformatics market with the largest market share of 44% in 2025.
• Asia Pacific is expected to expand at a solid CAGR of 18.5% during the forecast period.
• By product, the bioinformatics services segment led the market in 2025.
• By product, the bioinformatics platforms segment is expanding at a notable CAGR during the forecast period.
• By application, the genomic segment dominated the market in 2025.

Market Overview

The combination of biology and information technology is known as bioinformatics. There are a number of tools and software that are regularly utilized in data creation, data management, data warehousing and even data mining. The expansion of pharmaceutical sector has directly helped the growth of bioinformatics market. The impact of the COVID 19 pandemic was positive on this market as it helped open up new opportunities for the industry. Bioinformatics is widely utilized for the development of drugs and vaccines since the pandemic. A growing need for bioinformatics in the process of novel drug research and development has pushed the market growth. Many software are available easily today for the bioinformatics, which are user-friendly. There is an increase in public as well as private funding for the support of research activities will be expected to further help the expansion of the bioinformatics market during the forecast period.

Role of Artificial Intelligence (AI) in bioinformatics

Artificial Intelligence (AI) is finding wide application in biology and information technology sector. This has extended into the field of bioinformatics. The usage of AI is being slowly but steadily integrated into the bioinformatics infrastructure. AI technology combined with machine learning (ML) is helping in extraction of patterns from vast amounts of data to help make informed decisions. The acceleration of the process of drug discovery has become a reality with AI technology. Other benefits of AI in bioinformatics are efficiency, quicker drug discovery, improved prediction models and assistance in personalized medicine. The bioinformatics market is evolving and integration of advanced technology like AI will further boost the market in the forecast period.

Bioinformatics Market Growth Factors

• A factor boosting the growth of global bioinformatics market is growing investments in biology and information technology sectors. Moreover, government all around the world is taking constant efforts for the development of global bioinformatics market.
• To offer latest and new products and maintain their market positions around the globe, major market players in the global bioinformatics market are using various methods such as collaborations and acquisitions with other organizations.
• The bioinformatics tools and software are mostly used for cutting down the extra cost and expenses related to drug development process. This factor is supporting the growth of global bioinformatics market.
• To offer latest and new products and maintain their market positions around the globe, major market players in the global bioinformatics market are using various methods such as collaborations and acquisitions with other organizations.
• The release of technologically developed bioinformatics tools and software such as AUTODOCK, BALL, and RasMol as well as increased market utilization of these tools for accurate and precise analysis of biomarkers discovery programs that aid in contamination sensing during the early stages of the drug development process are expected to propel growth.

Market Scope

Market Dynamics

Drivers

Increase in funding from Government and Private Organizations

The governments around the world as well as the private organizations are investing extensively in the field of bioinformatics. The increase in funding and availability of resources is helping integration of technological advancements into the industry. The infrastructure improvement and scope of innovation rises with availability of resources. The field which is seeing more development in the current scenario is genomics. In genomics, huge amounts of data need to be analyzed and technological advancements are helping provide insightful data. The rising funding from public and private sector is helping driving the bioinformatics market.

Restraint

Cost of equipment

The advancements in technology and availability of tools have increased the precision and speed of bioinformatics industry. These tools are easily available and user friendly to an extent, but require certain level of advanced computer infrastructure and expertise to operate the tools properly. The operation of advanced features as well as instruments need a suitable infrastructure with the capacity to handle such heavy technological functions. This cost of equipment and enhancement of infrastructure is not ease for companies that small or medium size. It necessitates monetary investment which is a challenge for some organizations in the bioinformatics market.

Opportunity

Utilizing bioinformatics in personalized medicine

The rising demand for personalized medicine is growing across the world. The trend for personalized medicine is relatively new in healthcare and there are many avenues left unexplored. The awareness and acceptance amongst the people regarding personalized medicine has led to its rising demand. The development of such customized and personalized medicine could cater to a completely new consumer base. Technological advancement like artificial intelligence (AI) makes the process of discovery and implementation of personalized medicine slightly easier. The application of bioinformatics in personalized medicine could present a new opportunity for the bioinformatics market.

Segment Insights

Product Insights

The bioinformatics services segment dominated the bioinformatics market in 2022. The factors such as growing initiatives regarding research and development as well as surge in demand for novel drugs are boosting the growth of bioinformatics services segment. Furthermore, the technological advancements are resulting into the growing demand for bioinformatics services in the global market.

The bioinformatics platforms segment is fastest growing segment of the bioinformatics market in 2024. The growing usage of various tools for database management is driving the growth of bioinformatics platforms. The high utilization of next generation sequencing is also contributing to the growth of bioinformatics platforms. In addition, the growing demand for exome and genome technologies is driving the segment growth.

Application Insights

The genomic segment dominated the bioinformatics market in 2022. The demand for bioinformatics is growing in genomics due to adoption of new and innovative technologies. The bioinformatics in pharmacogenomics are used for handling and managing large amount of data and information in database. The sequencing technology is widely used in drug development process. This is directly impacting the growth of genomic segment over the forecast period.

The proteomics segment is fastest growing segment of the bioinformatics market in 2024. The growth of proteomics segment is attributed to the rising research and development initiatives and high investments for the development of technologies. These technologies help to analyze and manage data on a large scale. Moreover, algorithms are also used for managing and monitoring data in database. All these factors are driving the growth of the proteomics segment.

Regional Insights

Why Is North America Leading the Bioinformatics Market?

North America dominated the bioinformatics market in 2025. The bioinformatics market in North America is growing due to the favorable government regulations in favor of market players. In addition, the growth of North America bioinformatics market is also attributed to the existence of major market players. The government of the U.S. is investing towards the development of bioinformatics market. Furthermore, expanding research and development activities are paving way for the expansion of bioinformatics market in the region.

U.S. Bioinformatics Market Size and Growth 2026 to 2035

The U.S. bioinformatics market size was exhibited at USD 5.76 billion in 2025 and is projected to be worth around USD 17.82 billion by 2035, growing at a CAGR of 11.96% from 2026 to 2035.

U.S. Bioinformatics Market Trends

The U.S. has seen a steady growth in the bioinformatics market. The growth of the market is driven by increasing public and private-sector funding for research and development, rising demand for precision medicine in the country fuels the growth, higher pharma biotech R&D expenditure, and reduced genome sequencing costs, further fueling the growth in the region. Advances in technology, like the development of new sequencing technologies, cloud computing solutions, and big data analytics tools, have enabled the analysis of large amounts of biological data. Bioinformatics plays a crucial role in translating genomic data into clinical actions, enabling personalized treatment plans. These applications drive the growth of the market in the country and also support expansion.

What Is Driving the Growth of the Bioinformatics Market in Europe?

Europe, on the other hand, is expected to develop at the fastest rate during the forecast period. The UK, Italy, and France dominate the bioinformatics market in Europe region. The growing investments in healthcare sector are driving the growth of Europe bioinformatics market. Moreover, the adoption of innovative technologies such as artificial intelligence and internet of things are contributing towards the growth of bioinformatics market in Europe. The market players operating in Europe bioinformatics market are adopting strategies such as partnership and acquisition.

UK Bioinformatics Market Trends

The UK has seen a significant growth in the bioinformatics market, and the growth is driven by the Increased Research and Development Expenditure, as both public and private sector funding for bioinformatics research and development are driving the market in the country. Bioinformatics is increasingly used in pharmaceuticals, healthcare, agriculture, and other sectors, which further boosts the growth of the market in the country. Integration of Cloud Computing and Big Data Analytics. These technologies provide scalable solutions for handling and analyzing large datasets in bioinformatics, further helping the market to grow in the country and supporting the expansion of the market.

Company Profiles

Thermo Fisher Scientific, Inc.

• HQ: Massachusetts, United States
• Founded: 2006
• Ownership: Public (NYSE: TMO)
• Business Overview: Thermo Fisher Scientific, Inc. is a leading contract development and manufacturing organization (CDMO) and offers clinical trial solutions. It provides cutting-edge technologies and services that are the result of significant investment in research and development.
• Products: The company provides comprehensive bioinformatics solutions and services that provide end-to-end bioinformatics solutions for next-generation sequencing (NGS). It also offers by-the-hour consulting and customizable prepaid packages for on-site software and IT upgrades.
• Geographic Presence: Thermo Fisher Scientific is present globally across the Americas, Asia-Pacific, and EMEA.
• Recent Development: In July 2025, Thermo Fisher Scientific collaborated with GenNext Technologies to provide a simplified structural biology workflow designed to improve biotherapeutic development.
• Key Strategies: The company aims to be an indispensable partner across research, diagnostics, and biopharma production workflows.

Eurofins Scientific

• HQ: Luxembourg City, Luxembourg
• Founded: 1987
• Ownership: Public
• Business Overview: Eurofins Scientific SE is a French group of laboratories and a leading provider of analytical testing services. It is a leader in food, environment, pharmaceutical, and cosmetic product testing, as well as in discovery pharmacology, forensics, advanced materials science, and agroscience contract research services.
• Products: Eurofins Genomics offers a comprehensive suite of bioinformatics services, leveraging extensive experience in cutting-edge data analysis to convert next-generation sequencing data into valuable, actionable insights.
• Geographic Presence: Eurofins is present in Morocco (Africa); the U.S. (Americas); Cambodia, India, China, Vietnam, and Bangladesh (Asia); Germany, France, Italy, Poland, Türkiye, and the UK (Europe).
• Key Strategies: The company aims for a growth strategy centered on decentralized entrepreneurship, network scale, and leadership in specialized life sciences testing markets.

Illumina, Inc.

• HQ: California, United States
• Founded: 1998
• Ownership: Public (NASDAQ: ILMN)
• Business Overview: Illumina is an American biotechnology company that provides sequencing and array technologies, driving advances in life science research, translational and consumer genomics, and molecular diagnostics.
• Products: The company offers bioinformatics software tools and informatics services for next-generation sequencing and microarray technologies that help researchers transform complex genomic data into insights.
• Geographic Presence: Illumina operates in more than 165 countries, with a large presence in California, San Diego, and the Bay Area. It is also present in the UK and Singapore, with growing offices in Europe, Asia, and the Americas.
• Recent Development: In January 2026, Illumina, Inc. launched Illumina Connected Multiomics, a powerful cloud-based research software platform to analyze and visualize multiomic and multimodal biological data at scale.
• Key Strategies: Illumina focuses on applying innovative technologies for the analysis of genetic variation and function by delivering innovative, flexible, and scalable solutions.

QIAGEN N.V.

• HQ: Hilden, Germany
• Founded: 1984
• Ownership: Public (NYSE: QGEN)
• Business Overview: QIAGEN is a German-based company that provides products and services that enable customers to advance science, improve patient outcomes, and gain valuable insights from biological samples.
• Products: The company provides proprietary bioinformatics products and services, supporting the life science research and pharma discovery communities through curation, data analysis, and custom solutions.
• Geographic Presence: QIAGEN operates 35 subsidiaries across more than 25 countries, supported by a global distribution partner network spanning more than 60 countries.
• Recent Development: In May 2026, QIAGEN's Digital Insights bioinformatics division collaborated with NVIDIA's accelerated computing and the BioNeMo platform to enhance AI-driven drug discovery.
• Key Strategies: The company's main goal is to align its investments to maximize sales in proven high-growth markets, targeting at least $2 billion in net sales (CER) from growth pillars in 2028.

Agilent Technologies

• HQ: California, United States
• Founded: 1999
• Ownership: Public (NYSE: A)
• Business Overview: Agilent Technologies is an American life science company that provides a wide range of services, products, and software, enabling customers to produce the most accurate and reliable results as well as optimal scientific, economic, and operational outcomes.
• Products: Agilent offers a wide range of high-quality genomics and informatics software solutions for automated and standardized data analysis. Its software solutions for NGS include OpenLab Sync, Alissa Align & Cell, and SureDesign, and those for gene expression include eArray and GeneSpring GX.
• Geographic Presence: Agilent has a presence in multiple locations across the globe, including the Americas, Europe, and Asia-Pacific, serving customers in more than 110 countries.
• Recent Development: In November 2024, Agilent Technologies and Tagomics Ltd. signed a strategic co-marketing agreement to enhance access to their innovative offerings through an exclusive technology access program.
• Key Strategies: The company focuses on combining hardware sales with ongoing services, creating sustainable revenue cycles.

Bioinformatics Market Companies

• Thermo Fisher Scientific Inc.
• Eurofins Scientific
• QIAGEN N.V.
• Agilent Technologies Inc.
• Illumina Inc.
• Waters Corporation
• NeoGenomics Laboratories
• Perkin Elmer Inc.
• Fios Genomics
• Source BioScience

Key Developments

• In November 2024, Indonesia strengthened their ASEAN collaboration on bioinformatics with USAID funding. This step was taken with an aim to prevent future health threats.
• In August 2024, Inocras announced that will offer high quality and affordable whole genome sequencing and bioinformatics on their Ultima UG 100TM platform.
• In June 2024, WashU Medicine launched a Center for Translational Bioinformatics. This center is expected to support new collaborations as well as offer infrastructure to quicken precision medicine.

Segments Covered in the Report

By Product

• Bioinformatics Platforms
• Sequence Analysis Platform
• Sequence Alignment Platform
• Sequence Manipulation Platform
• Structural and Functional Analysis Platform
• Other
• Bioinformatics Services
• Sequencing Services
• Database and Management Services
• Data Analysis
• Other
• Knowledge Management Tools
• Generalized Knowledge Management Tools
• Specialized Knowledge Management Tools
• Biocontent

By Application

• Genomics
• Molecular Phylogenetics
• Metabolomics
• Proteomics
• Transcriptions
• Chemoinformatics and Drug Designing
• Others

By Sector

• Medical Biotechnology
• Animal Biotechnology
• Plant Biotechnology
• Environmental Biotechnology
• Forensic Biotechnology
• Other Sectors

By Geography

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa